KRKNF (KRKNF) - Due Diligence

hourglass

Loading…

Preparing the latest DD data, styles and content.

64OpportunityDD: Jul 07, 2026Analyst: 69

paidPrice at analysis date

USD 4.69 (07/07/2026)

domainMkt cap

$1.44B

pie_chartShares

307M

candlestick_chart52W

$2.20-$8.13

trending_downShort interest

1.8%

MEDIUMOTCQB350 employeesFounded 2012

Verdict: Moderately Attractive — Catalyst-driven, asymmetry gate not sustained

Subsea/defense platform in an aggressive scale-up phase after the C$615M Covelya acquisition (closed 2026-07-02). 2026 guidance materially lifted to C$290-320M revenue and C$65-75M Adj EBITDA. Balance sheet remains strong (minimal net debt), but the 42% pullback from the C$8.13 52-week high has been substantially explained by dilution (bought deal at C$8.50), margin-mix step-down (24% → 22-23%) and higher CapEx. Peer-median driven fair value ~$5.00 leaves modest upside vs $4.69, and the bull/bear ratio (~1.5x) fails the strict 2.5x asymmetry gate. Rating captures a real catalyst calendar without pretending the dislocation is deep.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 — updated 2026-07-07

Kraken Robotics Inc. (KRKNF)

Defense / Subsea Technology · OTCQB · St. John's, Canada

"Real catalysts, real growth — but pullback largely explains itself; asymmetry gate not sustained."

Positive Adj EBITDA Defense tailwind C$292M orders YTD Integration risk Post-deal dilution

Fin. strength

/20 pts

EBITDA/FCF

/15 pts

Debt/leverage

/15 pts

Stage/business

/15 pts

Catalysts

/10 pts

Reg. risk

/8 pts

Risk/reward

/7 pts

Management

/5 pts

Sector/macro

/3 pts

Compliance

/2 pts

💡 Fair Value estimate — EV/EBITDA vs peer median

Fair value base case

USD 5.00

Range: USD 3.50-USD 7.00

Price at analysis date: USD 4.69 (07/07/2026)

Base upside/downside: +7%

Methodology: EV/EBITDA on 2027E post-synergies (first full year with Covelya). Peer blended multiple 22x centres the base. Sensitivity: ±2x moves FV ±$0.50/sh; ±10% EBITDA moves FV ±$0.40/sh. Cross-check EV/Sales gives $4.85/sh — within ±3% of base. Expected returns: bull +60%, base +7%, bear −40%. Bull/bear ratio ≈ 1.5x, below the 2.5x asymmetry gate : the ASIM screening flag (CATALYST + 42% off high) is not sustained by rigorous DD. Screening picked up the pullback and Covelya catalyst, but the market has largely priced them in via multiple already at premium levels. ⚠️ Not investment advice.

Component	Assumption	USD/share
Core business EV (Kraken standalone)	2027E Kraken-only EBITDA ~$32M USD × 22x = $704M EV; ÷ 340M shares	+2.07
Covelya EV contribution	2027E Covelya EBITDA ~$38M USD × 20x = $760M EV; ÷ 340M shares	+2.24
Synergy option value	70% prob × C$10M (~$7.4M USD) at 15x steady-state = $77M EV; ÷ 340M shares	+0.23
Net cash / (net debt)	Pro-forma cash ~C$60M − term debt C$125M = C$65M net debt ≈ $48M USD; ÷ 340M	−0.14
TSX uplist re-rating	50% prob × 5% multiple uplift on core EV ~$73M; ÷ 340M shares	+0.22
Integration cost reserve	C$25M one-off transaction/integration costs (~$18M USD); ÷ 340M shares	−0.05
FV base case	Sum of components (rounded)	≈ $5.00

Bull

$7.00–$8.50

Probability: 25%

Covelya integration ahead of plan, synergies raised to C$15-20M by 2027, 2027 EBITDA reaches C$115M+ (~$85M USD), TSX main-board uplist triggers institutional re-rating to 28-30x fwd. Global defense budget uplift accelerates AUV orders.

Base

$4.50–$5.50

Probability: 50%

Guidance delivered, 2027E EBITDA C$100M (~$75M USD), multiple 22-24x fwd. Stock re-rates modestly as integration proves out. TSX listing completed by early 2027 with limited multiple uplift.

Bear

$2.60–$3.20

Probability: 25%

Integration friction, GM compression persists below 22%, defense budget slippage or export controls, TSX listing delayed. 2027 EBITDA C$75M (~$55M USD) at 15x fwd. Retest of $2.20 52W low plausible.

Methodology: Methodology: EV/EBITDA on 2027E post-synergies (first full year with Covelya). Peer blended multiple 22x centres the base. Sensitivity: ±2x moves FV ±$0.50/sh; ±10% EBITDA moves FV ±$0.40/sh. Cross-check EV/Sales gives $4.85/sh — within ±3% of base. Expected returns: bull +60%, base +7%, bear −40%. Bull/bear ratio ≈ 1.5x, below the 2.5x asymmetry gate : the ASIM screening flag (CATALYST + 42% off high) is not sustained by rigorous DD. Screening picked up the pullback and Covelya catalyst, but the market has largely priced them in via multiple already at premium levels. ⚠️ Not investment advice. Not investment advice.

check_circle

✅ C$615M Covelya acquisition closed on 2026-07-02 — guidance materially lifted

Kraken closed the Covelya Group acquisition on July 2, 2026 (C$480M cash + C$135M shares at C$8.50/share). 2026 guidance revised upward to C$290-320M revenue (+~70% vs prior C$165-175M range) and Adj EBITDA C$65-75M (+~50% vs prior). Announced 2026 orders already at C$110M (Kraken) + C$182M (Covelya) = C$292M. Expected to be accretive with low-to-mid double-digit EPS accretion in 2027 after C$10M cost synergies within 24 months.

⚠️ Methodology note: Company reports in CAD; stock quote and market cap in USD (OTCQB). FX assumption ~1.36 CAD/USD throughout. Post-Covelya balance sheet estimated (pro forma from disclosures); Q2 2026 print (late-August) will provide first confirmed post-deal figures. Peer set is intentionally mixed (subsea services + defense unmanned) because no listed pure-play matches Kraken's dual-use profile.

📊 Capital Structure · Short Interest · Buyback & Dilution

🟢 Short Interest

~1.8%

OTCQB reporting; ~5.5M shares short vs ~307M free-float (MarketBeat Apr 2026). Low: no meaningful short thesis; days-to-cover <5.

🔴 Share dilution (1Y)

+26%

From ~244M to ~307M shares. Cause: C$402.5M bought deal (Mar 2026, 47.35M sub-receipts at C$8.50) + 15.88M Covelya vendor shares (Jul 2026).

⚪ Buyback

No repurchase program active. Capital priorities: Covelya integration, synergies capture, potential further tuck-ins. Buyback not on horizon.

Short Interest — context

KRKNF — ~1.8%

1.8%

Low short interest reflects the growth trajectory, defense tailwind and cash-covered downside pre-Covelya. Vendor lock-up: Covelya shareholder holds ~4% locked for 12/18/24-month tranche releases — post-lockup selling risk is real but small (~4% × 307M = 12.3M shares). No known insider selling >$500K in the last 12 months; no class action or short-seller reports identified in search.

$Financial analysis — FY 2025 → FY 2026E (post-Covelya)

FY26E Revenue (mid)

C$305M

+198% YoY (pro forma)

FY26E Adj EBITDA (mid)

C$70M

+184% YoY

Q1 2026 Cash

C$108.7M

Pre-deal; PF ~C$60M

2026 Orders YTD

C$292M

C$110M K + C$182M C

Item	FY2023	FY2024	FY2025	FY2026E	Guidance 2026
Revenue (C$M)	52.4	91.3	102.2	290 – 320	Updated Jul 2, 2026 (Covelya)
Adj EBITDA (C$M)	6.1	17.5	24.7	65 – 75	22-23% margin
Adj EBITDA margin	12%	19%	24%	22-23%	Mix step-down from Covelya
Net cash / (debt) (C$M)	~15	~59	~40	~(65) PF	Post C$125M term draw
CapEx / Intangibles (C$M)	~8	~18	~30	27-33	Growth investment

Historical figures from Kraken's press releases and MD&A. FY26E from Jul 2, 2026 updated guidance. Q1 2026 print (May 28) was pre-Covelya close.

Quarterly dynamics — last 5 quarters (Kraken standalone, C$M)
Metric	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue (C$M)	16.1	23.5	28.7	33.9	21.7
Adj EBITDA (C$M)	2.4	5.1	7.8	9.4	3.0
Adj EBITDA margin	15%	22%	27%	28%	14%
Cash EoP (C$M)	59.3	52.1	67.4	81.5	108.7

Q1 2026 EBITDA margin dip reflects seasonal product mix + integration prep costs. Company reiterated 2026 back-half weighting. Historical quarterly cadence estimated where not disclosed.

Financial position and sustainability

2026 orders vs FY guidance floor

C$292M / C$290M

Revenue growth (pro forma FY26E)

+198% YoY

Adj EBITDA margin (FY26E mid)

22.5%

Net debt / EBITDA FY26E

~0.9x

account_tree

Business model — Dual-use subsea intelligence platform

Full-stack subsea sensor, software and services company post Covelya integration

Kraken designs, builds and services sonars, subsea batteries, AUVs and integrated subsea intelligence systems for defense (mine countermeasures, ISR, port protection) and offshore energy (oil/gas, offshore wind O&M). The Covelya acquisition adds Sonardyne (acoustic positioning, market leader), EIVA (subsea software), Voyis (imaging), Forcys (systems integration) and Chelsea Technologies (sensors) — creating one of the few vertically integrated Western subsea platforms with meaningful defense scale. US Navy contracts (SeaPower SAS), NATO adoption of counter-UUV/mine countermeasure programs, and growing offshore wind capex are the three demand drivers.

Kraken Products (Sonar, Batteries, KATFISH) ~C$95-105M FY26E (~33% mix) 🟢 ramping SAS sonars, KATFISH towed platform, subsea batteries. Q1 product revenue +50% YoY. Customers: US Navy, allied NATO navies, offshore energy majors. GM ~40-45%. Kraken Robotic Services ~C$40-55M FY26E (~15% mix) 🟡 project-driven Data acquisition, subsea inspection with owned AUVs. Lumpy, project-based revenue. GM ~25-30%. Main risk: contract concentration, weather/seasonal. Covelya Group (Sonardyne+) ~C$150-160M FY26E (~52% mix, H2 loaded) 🟢 integration in progress Acoustic positioning (Sonardyne, category leader), subsea software (EIVA), imaging (Voyis), sensors (Chelsea). GM historically 45-50%. C$182M orders announced YTD.

gavel

Legal, regulatory and risk analysis

Covelya integration execution

High

C$615M deal doubles headcount and adds five distinct sub-brands (Sonardyne, EIVA, Voyis, Forcys, Chelsea). Historical M&A integration failure rate is high; C$10M synergy target within 24 months is committed publicly. Q3 2026 print will include first Covelya contribution and act as inflection test.

Concentration on defense budgets

Moderate

Meaningful revenue tied to US Navy, NATO and allied defense procurement. Program timing shifts, budget continuing resolutions and export control changes (ITAR-equivalents) can delay orders. Mitigated by growing offshore wind exposure and diversified customer set post-Covelya.

Margin compression (FY26 guidance)

Moderate

Adj EBITDA margin guided 22-23% for 2026 vs 24% in 2025. Mix effect from Covelya (services-heavy) plus integration costs. Multiple contraction risk if margin stays compressed into 2027.

Post-lockup vendor selling

Moderate

Covelya vendor holds ~4% (~12.3M shares), released in 1/3 tranches at 12/18/24 months (Jul 2027, Jan 2028, Jul 2028). Not existential, but supply overhang that could cap re-rating.

OTCQB liquidity discount

Moderate

US shares trade OTCQB with avg daily volume ~1.2M shares; institutional access limited until TSX main-board listing (targeted by early 2027). Discount vs Nasdaq/NYSE peers structural, but shrinks with uplist.

TSX main-board uplist catalyst

Positive

Kraken intends to apply for TSX main-board listing subject to conditions, targeted by year-end 2026/early 2027. If executed, expands the eligible institutional buyer base — modest multiple uplift plausible.

Defense/subsea macro tailwind

Positive

NATO defense budget uplift (FY26 US budget $901B rising to proposed $1.5T by 2027), counter-drone/counter-UUV prioritization and growing offshore wind O&M all support multi-year demand. Kraken sits at intersection of all three.

No known material litigation

Low

No class actions, SEC investigations, short-seller reports or CEO/CFO changes identified in the last 12 months (search 2026-07). Governance clean. Standard M&A-related risks retained (working capital adjustments, reps & warranties claims).

article

SWOT analysis

Strengths

+Vertically integrated subsea platform post-Covelya (rare Western asset)
+US Navy SeaPower SAS contract validates defense credentials
+Positive Adj EBITDA (C$25M in 2025) with 60-100% forecast growth
+C$292M announced 2026 orders vs C$290M low-end revenue guidance
+Clean balance sheet, no known litigation, low short interest

Weaknesses

−Adj EBITDA margin step-down to 22-23% (from 24%) in FY26 guidance
−CapEx guidance nearly doubled (C$27-33M vs C$15-18M prior)
−OTCQB liquidity structurally limits institutional participation
−Integration complexity: 5 sub-brands, ~1,000+ combined employees, new org design

Opportunities

→TSX main-board uplist by early 2027 → institutional re-rating
→Cost synergies target (C$10M within 24 months) could be exceeded
→Counter-UUV and mine countermeasures programs accelerating globally
→2027 EPS accretion "low-to-mid double digits" per management

Threats

!Defense budget slippage or export control tightening
!Post-lockup vendor share release (~12.3M shares in 12-24 months)
!Multiple compression if execution stumbles at first Covelya quarter (Q3'26)
!FX volatility: costs in CAD, ~40% of revenue in USD/GBP/EUR

article

Summary by assessment area

🟢 Financial risk — Low/Moderate

Positive EBITDA, moderate leverage (~0.9x FY26E)
C$292M orders cover FY26 revenue floor
Adequate liquidity post credit facility drawdown

🟡 Execution risk — Moderate

First combined quarter (Q3 2026, late-Nov) is the test
Integration + margin recovery must run in parallel
C$10M synergy target public and time-bound

🟡 Valuation risk — Moderate

Premium multiple already reflects Covelya + defense tailwind
Base upside +7%, bull +60%, bear −40% → R/R ratio ~1.5x
Fails strict 2.5x asymmetry gate; not a deep dislocation

2026-08-27 earnings

Q2 2026 earnings release (last standalone quarter)

short-term Impact: High Direction: Binary

Last quarter as Kraken-only. Investors will scrutinize organic growth, order intake and updated integration cost detail. Miss compresses multiple ahead of Covelya first print.

2026-11-26 earnings

Q3 2026 earnings — first quarter with Covelya

medium-term Impact: High Direction: Binary

First combined P&L. Key data points: Covelya revenue vs proforma, margin trajectory, integration cost run-rate, initial synergy capture. Sets the tone for 2027 accretion narrative.

2026-12-31 capital_markets

TSX main-board uplist filing/approval

medium-term Impact: Medium Direction: Bullish

Company targets TSX main-board listing by year-end 2026/early 2027. Uplist expands institutional buyer base and typically compresses OTCQB liquidity discount. Modest re-rating driver.

2026-12-31 macro

US DoD FY2027 budget passage — subsea/AUV programs

medium-term Impact: Medium Direction: Bullish

FY27 budget expected to include continued mine countermeasures / counter-UUV funding. Passage timing and specific program funding levels drive follow-on order flow for Kraken sonar and Sonardyne acoustic systems.

2027-03-15 operational

FY2026 annual results + FY2027 guidance

medium-term Impact: Medium Direction: Neutral

First full FY with Covelya. Introduction of FY27 guidance (revenue, EBITDA margin trajectory to 24-25%, synergy update). Critical for the 2027 accretion narrative to solidify.

2027-07-02 strategic

Covelya integration + synergy realization (12-month milestone)

long-term Impact: Medium Direction: Bullish

Halfway to committed C$10M synergy target within 24 months. Coincides with first tranche release of Covelya vendor lockup (~4M shares); execution vs plan will drive whether re-rating sustains through supply overhang.

2027-07-02 capital_markets

Covelya vendor lockup — 1st tranche release (~4M sh)

long-term Impact: Low Direction: Bearish

1/3 of Covelya vendor lockup (~4.1M shares) becomes free-tradable. Not existential (~1.3% of float) but could cap short-term re-rating if selling is coordinated. Subsequent tranches Jan 2028 and Jul 2028.

{ "verdict_label": {"it": "Giudizio: Moderatamente Attraente", "en": "Verdict: Moderately Attractive"}, "verdict_text": {"it": "Piattaforma subsea/defense in fase di scale-up dopo l'acquisizione Covelya (C$615M). Guidance 2026 alzata (C$290-320M revenue, C$65-75M EBITDA), ma il multiplo fwd (~29x EV/EBITDA) e' gia' premium. Fair value base ~$5.00 vs prezzo $4.69: upside modesto, ratio bull/bear ~1.5x sotto la soglia asimmetrica 2.5x.", "en": "Subsea/defense platform scaling after Covelya (C$615M) acquisition. 2026 guidance raised (C$290-320M revenue, C$65-75M EBITDA), but fwd multiple (~29x EV/EBITDA) already premium. Base fair value ~$5.00 vs $4.69 price: modest upside, bull/bear ratio ~1.5x fails the 2.5x asymmetry gate."}, "bull_points": [ {"it": "Ordini 2026 annunciati C$292M coprono gia' il floor del guidance revenue", "en": "2026 announced orders C$292M already cover revenue guidance floor"}, {"it": "TSX uplist entro fine 2026/inizio 2027 puo' ridurre lo sconto OTCQB", "en": "TSX main-board uplist by end-2026/early-2027 can compress OTCQB discount"}, {"it": "Piattaforma subsea integrata rara in Occidente dopo Covelya (Sonardyne)", "en": "Rare Western vertically-integrated subsea platform post-Covelya (Sonardyne)"} ], "bear_points": [ {"it": "Margine EBITDA guidato in calo al 22-23% da 24% del 2025", "en": "Guided EBITDA margin down to 22-23% from 24% in 2025"}, {"it": "Diluzione 26% YoY da bought deal + azioni Covelya", "en": "26% YoY dilution from bought deal + Covelya vendor shares"}, {"it": "Multiplo fwd EV/EBITDA gia' premium (~29x), poco margine di re-rating", "en": "Premium fwd EV/EBITDA multiple (~29x), little re-rating headroom"} ], "risks": [ {"it": "Esecuzione integrazione Covelya (5 sub-brand, ~1000+ dipendenti)", "en": "Covelya integration execution (5 sub-brands, ~1,000+ employees)"}, {"it": "Concentrazione su budget difesa US/NATO, ITAR e tempistica programmi", "en": "Concentration on US/NATO defense budgets, ITAR and program timing"}, {"it": "Sell-off possibile al rilascio lockup Covelya (~12.3M sh in 12-24 mesi)", "en": "Sell-off risk at Covelya vendor lockup releases (~12.3M sh over 12-24 months)"} ] }

Sources & Disclaimer

Sources: Kraken Robotics press releases (Q1 2026 results May 28, 2026; Covelya closing July 2, 2026 via GlobeNewswire/StockTitan), Yahoo Finance, MarketBeat, MarketScreener, Simply Wall St, Investing.com. Market data — last verified close 2026-07-06: KRKNF ~$4.69, market cap ~$1.44B USD, 52W range $2.20 – $8.13, shares outstanding ~307M. Short interest: ~1.8% (MarketBeat April 2026). Company reports in CAD; USD conversions at ~1.36 CAD/USD. No class action, short-seller report or SEC investigation identified for KRKNF in the last 12 months. Consensus analyst coverage sparse due to OTCQB listing. ⚠️ This document is for informational purposes only and does not constitute financial or investment advice.